News from NIAID-Supported Institutions
National Institute of Allergy and Infectious Diseases sent this bulletin at 12/21/2012 09:35 AM EST Here’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:UNC Researchers Discover How Hepatitis C Virus Reprograms Human Liver Cells
December 18, 2012—University of North Carolina
Method to Make One-Way Flu Vaccine Discovered by Georgia State University Researcher
December 18, 2012—Georgia State University
University of Maryland School of Medicine to Study Drug-Resistant Malaria in Newly Open Nation of Myanmar/Burma
December 17, 2012—University of Maryland School of Medicine
Ebola Virus Uses Protein Decoy to Subvert the Host Immune Response
December 14, 2012—Emory University
A Drug Used to Treat HIV Might Defuse Deadly Staph Infections
December 14, 2012—NYU School of Medicine
Dark Ages Scourge Enlightens Modern Struggle Between Man and Microbes
December 13, 2012—University of Washington
Intestinal Immune Cells Play an Unexpected Role in Immune Surveillance of the Bloodstream
December 13, 2012—Massachusetts General Hospital
UGA Researchers Find Algal Ancestor is Key to How Deadly Pathogens Proliferate
December 12, 2012—University of Georgia
How Hepatitis C Virus Harms the Liver
December 12, 2012—University of Southern California
Isotechnika Pharma’s NICAM Compounds Demonstrate Positive Anti-Hepatitis C Virus Activity in Secondary Level Testing at NIH-Funded Labs
December 6, 2012—Isotechnika Pharma Inc.
These news releases were issued by organizations supported by NIAID.
No hay comentarios:
Publicar un comentario